486 related articles for article (PubMed ID: 16038768)
1. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.
Patrício FJ; Costa GC; Pereira PV; Aragão-Filho WC; Sousa SM; Frazão JB; Pereira WS; Maciel MC; Silva LA; Amaral FM; Rebêlo JM; Guerra RN; Ribeiro MN; Nascimento FR
J Ethnopharmacol; 2008 Jan; 115(2):313-9. PubMed ID: 18035510
[TBL] [Abstract][Full Text] [Related]
3. Effect of the Synadenium carinatum latex lectin (ScLL) on Leishmania (Leishmania) amazonensis infection in murine macrophages.
Afonso-Cardoso SR; Silva CV; Ferreira MS; Souza MA
Exp Parasitol; 2011 May; 128(1):61-7. PubMed ID: 21320493
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of components from leaves of Calophyllum brasiliense against Leishmania (Leishmania) amazonensis.
Honda PA; Ferreira IC; Cortez DA; Amado CA; Silveira TG; Brenzan MA; Lonardoni MV
Phytomedicine; 2010 Apr; 17(5):333-8. PubMed ID: 19800777
[TBL] [Abstract][Full Text] [Related]
5. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
6. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
[TBL] [Abstract][Full Text] [Related]
7. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro control of Leishmania mexicana due to garlic-induced NO production.
Gamboa-León MR; Aranda-González I; Mut-Martín M; García-Miss MR; Dumonteil E
Scand J Immunol; 2007 Nov; 66(5):508-14. PubMed ID: 17953527
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin modulates macrophage functions of Leishmania (L.) amazonensis-infected BALB/c mice.
Kückelhaus CS; Kückelhaus SA; Tosta CE; Muniz-Junqueira MI
Exp Parasitol; 2013 May; 134(1):18-25. PubMed ID: 23402845
[TBL] [Abstract][Full Text] [Related]
11. Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro.
Vendrame CM; Carvalho MD; Rios FJ; Manuli ER; Petitto-Assis F; Goto H
Scand J Immunol; 2007; 66(2-3):287-96. PubMed ID: 17635806
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
13. Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection.
Vanloubbeeck Y; Jones DE
Am J Trop Med Hyg; 2004 Oct; 71(4):407-11. PubMed ID: 15516635
[TBL] [Abstract][Full Text] [Related]
14. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.
Aranha FC; Ribeiro U; Basse P; Corbett CE; Laurenti MD
Scand J Immunol; 2005 Oct; 62(4):334-41. PubMed ID: 16253120
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.
Miguel DC; Yokoyama-Yasunaka JK; Andreoli WK; Mortara RA; Uliana SR
J Antimicrob Chemother; 2007 Sep; 60(3):526-34. PubMed ID: 17584801
[TBL] [Abstract][Full Text] [Related]
17. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Leishmania (Leishmania) amazonensis growth and infectivity by aureobasidin A.
Tanaka AK; Valero VB; Takahashi HK; Straus AH
J Antimicrob Chemother; 2007 Mar; 59(3):487-92. PubMed ID: 17242034
[TBL] [Abstract][Full Text] [Related]
19. Hairless mice as an experimental model of infection with Leishmania (Leishmania) amazonensis.
Araujo VC; Fukutani KF; Oshiro ET; Rodrigues PO; Rizk YS; Carollo CA; Arruda CC
Exp Parasitol; 2015 Oct; 157():138-44. PubMed ID: 26234915
[TBL] [Abstract][Full Text] [Related]
20. Leishmania amazonensis infection does not inhibit systemic nitric oxide levels elicited by lipopolysaccharide in vivo.
Linares E; Augusto O; Barão SC; Giorgio S
J Parasitol; 2000 Feb; 86(1):78-82. PubMed ID: 10701568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
